Comparing Clinical Evidence Tools: What Surgeons Actually Need
An honest comparison of evidence platforms available to UK surgeons, from UpToDate to OpenEvidence.
UK surgeons have more evidence tools than ever, but most were designed for researchers, students, or American healthcare. Here's what each tool does well — and where they fall short for surgical practice.
UpToDate
Strengths: Comprehensive, peer-reviewed, trusted by institutions.
Limitations: $499/year individual subscription. Content is US-centric and doesn't integrate with UK trust guidelines or NICE. The mobile app has persistent performance issues.
OpenEvidence
Strengths: AI-powered, fast, growing rapidly (40%+ US physician adoption).
Limitations: Prohibits copying or saving answers. UK-specific evidence gaps — may contradict NICE guidelines without flagging the discrepancy. No local guideline integration.
EOLAS
Strengths: Strong UK market presence (80% NHS trusts), excellent guideline management.
Limitations: MicroGuide transition causing user frustration. Limited AI capabilities. No evidence synthesis beyond guideline search.
What's Missing
None of these tools combine: - Your trust's local guidelines - National guidance (NICE, SIGN) - Primary research (PubMed, OpenAlex) - Automatic conflict highlighting - Surgery-first interface design
This gap is exactly what Torr Health was built to fill.
Ask Torr Health about this topic
Get evidence-based answers with citations from NICE, PubMed, and your trust's guidelines.
Try Torr Health free